XOMA Royalty Corp. (XOMA)
26.50
-3.35
(-11.22%)
USD |
NASDAQ |
Jan 12, 09:57
XOMA Royalty Research and Development Expense (Quarterly): 0.069M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 42.90M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Rezolute, Inc. | 13.15M |
| Vistagen Therapeutics, Inc. | 15.86M |
| Zevra Therapeutics, Inc. | 3.432M |